ROCKET PHARMACEUTICALS, INC. (16) | Business Finance (9)

Browse by Subcategory

Recent Contracts

Warrant to Purchase Shares of Common Stock dated as of December 21, 2020, by and between the Registrant and Neptune Consulting, LLC (Filed With SEC on March 1, 2021)
Underwriting Agreement, dated December 9, 2020, among Rocket Pharmaceuticals, Inc., J.P. Morgan Securities LLC, BofA Securities, Inc., SVB Leerink LLC and Piper Sandler & Co (Filed With SEC on December 11, 2020)
Second Supplemental Indenture, dated as of February 20, 2020, between Rocket Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee (incorporated by... (Filed With SEC on June 12, 2020)
Form of Restricted Stock Unit Award Agreement (Filed With SEC on March 6, 2020)
Form of Exchange Agreement (Filed With SEC on February 11, 2020)
Amendment to First Supplemental Indenture, dated as of February 18, 2020, between Rocket Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee (Filed With SEC on February 20, 2020)
Second Supplemental Indenture, dated as of February 20, 2020, between Rocket Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee (Filed With SEC on February 20, 2020)
Underwriting Agreement, dated December 10, 2019, among Rocket Pharmaceuticals, Inc., J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C (Filed With SEC on December 13, 2019)
Underwriting Agreement, dated April 15, 2019, among Rocket Pharmaceuticals, Inc., SVB Leerink LLC, Evercore Group L.L.C. and William Blair & Company, L.L.C (Filed With SEC on April 18, 2019)